IL-27 has been demonstrated to directly regulate IDO expression in tumor cells while stimulating tryptophan metabolite production, establishing a dual immunometabolic regulatory pattern particularly prominent in inflammatory microenvironments [26,27]. Here, IDO1 is linked to neoplasm.